Cue Biopharma, Inc. Operating Lease, Payments
Cue Biopharma, Inc. (CUE) reported Operating Lease, Payments of $709.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2023-11-03
- Cue Biopharma, Inc. operating lease, payments for the quarter ending 2023-09-30 was $709.00K, a 138.72% increase year-over-year.
- Cue Biopharma, Inc. operating lease, payments for the quarter ending 2023-06-30 was $702.00K, a 602.00% increase year-over-year.
- Cue Biopharma, Inc. operating lease, payments for the quarter ending 2023-03-31 was $652.00K, a 586.32% increase year-over-year.
- Cue Biopharma, Inc. operating lease, payments for the quarter ending 2022-09-30 was $297.00K, a 76.89% decline year-over-year.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month |
|---|---|---|---|---|
| 2023-09-30 | $709.00K 10-Q · filed 2023-11-03 | $1.41M derived: sum of 2 quarters · filed 2023-11-03 | $2.06M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $702.00K 10-Q · filed 2023-08-08 | $1.35M 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | $652.00K 10-Q · filed 2023-05-09 | |||
| 2022-09-30 | $297.00K 10-Q · filed 2022-11-14 | $397.00K derived: sum of 2 quarters · filed 2022-11-14 | $397.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-04 | $2.27M 10-Q · filed 2022-08-04 | ||
| 2022-03-31 | $95.00K 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | $1.28M 10-Q · filed 2021-11-09 | $2.57M derived: sum of 2 quarters · filed 2021-11-09 | $3.74M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.28M 10-Q · filed 2021-08-09 | $2.46M 10-Q · filed 2021-08-09 | ||
| 2020-09-30 | $1.17M 10-Q · filed 2020-11-09 | $2.06M derived: sum of 2 quarters · filed 2020-11-09 | $3.37M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $893.00K 10-Q · filed 2020-08-07 | $893.00K 10-Q · filed 2020-08-07 | ||
| 2020-03-31 | $1.17M 10-Q · filed 2021-05-10 | $893.00K 10-Q · filed 2020-05-07 | ||
| 2019-09-30 | $893.00K 10-Q · filed 2019-11-07 | $2.68M 10-Q · filed 2019-11-07 | ||
| 2019-03-31 | $756.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |